Jonathan Berlent Cure Pharmaceutical Holding Corp. (CURR) insider trading activity
Jonathan Berlent is Chief Business Officer of Cure Pharmaceutical Holding Corp.. Currently has a direct ownership of 10,000 shares of CURR, which is worth approximately $900. The most recent transaction as insider was on May 27, 2021, when has been sold 10,000 shares (Common Stock) at a price of $0.69 per share, resulting in proceeds of $6,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
10K
0%
3M change
0%
12M change
Total Value Held
$900
JB
Jonathan Berlent
Chief Business Officer
Oxnard, CA